Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
RTX-240 Monotherapy and in Combination With Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
- Status
- TERMINATED
- Phase
- PHASE2
HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dara-Pembro for Multiple Myeloma Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Study of SRF617 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
- Status
- COMPLETED
- Phase
- PHASE1
Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2